|
Summary
In the area of Neurosciences
at the Clínica Universitaria and the University of
Navarra, a combined group of researchers are involved in clincal
and basic research in an effort to determine the causes and
the most adequate treatments for disorders of the nervous
system. These research efforts are intimately linked to the
care that is offered to patients treated in the Neurology
department of the hospital and to the teaching of Neurosciences
in Navarra at all levels.
Objectives
Within the field of the neurosciences,
the 3 main research goals of the department are:
- The diagnosis and treatment
of illnesses involving the nervous system using the latest
available technology and knowledge, and in close coloboration
with other healthcare institutions both within Spain and
abroad;
- The study of the mechanisms,
pathogenesis and the treatment of neurological diseases;
and
- The teaching of the Neurosciences
at all levels, from undergraduate level to the training
of residents:
These objectives are closely
integrated such that the medical service offered to the patient
benefits from the latest research advances, and that the future
generations of doctors learn to care for their patients with
a sense of optimism founded on the real hope of an effective
cure.
Top
Research
Areas
The clinical service and research
efforts coincide in as much as they are centred on the treatment
of illnesses that owing to their frequency and the problems
they produce, generate serious problems in the area of healthcare
in Europe, Spain and Navarra.
Top
1) Motor disorders and other movement disorders
involving the basal ganglia
These illnesses cause a deterioration
in the ability of the patient to move freely. Although the
patients cognitive abilities often remain intact, the limitation
of their motor facilities means that many give the impression
of being mentally retarded or of impaired mental capacity.
The patients are often unable to work and require intensive
care and assistence from their families. The most common of
these illlnesses is that of Parkinson's disease, which principally
affects patients of 50 years or over, and whose frequency
grows in the more elderly. Approximately 20% of patients that
show signs of Parkinson's disease also suffer from other motor
diseases that require a specialized diagnosis and treatment.
Top
Parkinson's
Disease
There are approximately 70.000
sufferers of Parkinson's in Spain and some 1000 in Navarra
alone. A large number of these sufferers, particularly those
that have been treated for various years, don't respond to
the normal treatments or these treatment have important secondary
effects.
The Unit of Motor Disorders
in the CUN is specialized in the treatment of these patients.
Dr Maria del Rosario Luquin, in colaboration with Dr Miguel
Manrique, is studying the possibilty of treating patients
by transplanting cells from another part of their own nervous
system to replace those affected by the disease, thereby improving
their response to the disease. The value of these studies
has been recognised by awards from the Spanish Neurology Society
(Sociedad Española de Neurología) in 1999.
Dr José Obeso, Co-ordinator
of the Unit, is one of the World pioneers in the use of stimulation
of the subthalmic nucleus to treat patients that respond poorly
to the usual treatments. Along with Dr Maria Rodriguez in
the Unit, they have demonstrated the improvement shown by
a large proportion of these patients with this new treatment,
which when carried out carefully by experienced specialists,
is now accepted as an excellent treatment for patients who
don't respond to the usual therapy.
The Drs Julio Artieda, Maria
Asunción Pastor, y Javier Arbizu employ neurophysiological
and advanced neuroimaging techniques such as PET, to aid in
the diagnosis of complex cases and to identify the underlying
causes of these disorders.
Top
Other
illnesses that lead to motor disorders and restrictions
of movement
Other motor illnesses do not
behave in the same way as Parkinson's disease but still have
serious reprecussions on the health and well being of those
affected. Indeed, movement disorders in ageing people
are principally not the result of rheumatism but rather of
neurological disfunctions. After Alzheimer, movement disorders
are the major cause of chronic disability in people over 65
years of age. Dr. José Masdeu has performed pioneering studies
on the diagnosis and treatment of these problems as described
in his book "Gait Disorders of Aging," published
in the United States, where he was the director of the Neurology
department at the New York Medical College.
The Unit includes a group of
scientists whose prestige has been gained by mapping the nervous
tracts between the basal ganglia and the cerebral cortex,
and in studying the signals that are used for the communication
between these two areas. These studies have great importance
in helping to define the basis of the distinct neurodegenerative
illnesses, and as such, aid in the development of efficient
therapies.
Faculty Personnel
| Dr. Javier Arbizu |
Dr. Ma. Rosario Luquin |
Dr. Lourdes Ortiz Hernandez |
| Dr. Julio Artieda |
Dr. Miguel Manrique |
Dr. Asunción Pastor |
| Dr. Elena Erro Aguirre
(postdoc) |
Dr. José Masdeu |
Dr. Alberto Pérez Mediavilla |
| Dr. Jose Manuel Gimenez
Amaya |
Dr. Elisa Mengual Poza |
Dr. Lucía Prensa Sepúlveda |
| Dr. Jose Luis Lanciego
Perez |
Dr. José Obeso |
Dr. Ma. Cruz Rodriguez |
Top
2) Memory disorders
Particularly in elderly people,
memory disorders such as Alzheimer's disease and other types
of dementia are a primary public health problem. Epidemiological
studies, many carried out by Dr Martínez-Lage, have calculated
that there are nearly half a million sufferers of Alzheimer's
in Spain. This number reaches 675.000 when all the types of
dementias are taken into account and some 850.000 patients
that suffer isolated memory loss. In Navarra, these numbers
equate to 6.000, 8.000 y 11.000 sufferers. This unit is dedicated
to the treatment of these patients and to the study of more
efficient diagnostic and therapeutic aids. To this end, the
unit counts on sophisticated neuroimaging and research techniques
including PET and functional magnetic resonance. Dr. Gómez
Isla has also developed transgenic animals to experimentally
explore the roles of the genes implicated in Alzheimer, with
the aim of studying the origin of this illness and defining
new strategies for its treatment.
Depression can be attributed,
in a grand part, to biochemical disturbances in the brain. Dr
Del Río's team is collaborating in the development of more
efficient medications to treat this all-to-common problem.
Faculty Personnel
| Dr. Javier Arbizu |
Dr. Mª. Teresa Gómez
Isla |
| Dr. Edurne Cenarruzabeitia |
Dr. Berta Lasheras Aldaz |
| Dr. Pablo Martínez-Lage |
Dr. José Manuel Martínez-Lage |
| Dr. Joaquín Del Rio Zambrano |
Dr. José Masdeu |
Top
3) Tumours
of the Brain and Spinal cord
Although not as frequent as
other disorders of the nervous system, tumours often affect
younger people and their consequences may remain with them
throughout the rest of their lives. Some tumour types are
so malignant that they may prove to be fatal in a question
of weeks if not treated appropriately. In the CUN there is
an excellent programme for tumour treatment directed by Dr.
Antonio Burgarolas that has attained worldwide prestige. The
oncology unit is comprised of neurosurgeons, neuroradiologists
and neuropathologists who collaborate intimately with
Dr. Burgarolas group and with gene therapy groups, and that
has a depth of experience in treating patients with tumours
that affect the nervous system.
In the CUN, the treatment of
tumours in the nervous system benefits from the use of the
latest therapeutic and diagnostic techniques including PET,
a technique particularly useful in distinguishing the degree
of malignancy in cases of relapse, and radiosurgery that provides
a non-invasive treatment for tumours that previously could
only be treated surgically.
Medical
Personnel
in the Unit
| Dr. Bartolomé Bejarano |
Dr. Miguel Manrique |
| Dr. Michel Idoate |
Dr. José Luis Zubieta |
Top
4) Epilepsy
There are 380,000 people with
chronic epilepsy in Spain and 5,000 in Navarra. Approximately
70% of these patients can be adequately treated with medication
whilst the remaining sufferers require alternative treatments,
two of which require the close collaboration of neurologists
and neurosurgeons. In many cases, following a detailed study
of brain function and the location of the focal origin of
the epilepsy, surgical extirpation can successfully remediate
the attacks. However, in other patients, Vagal nerve stimulation
with portable modules permits the patient to exert a greater
control over their epileptic attacks. The doctors in this
unit have worked in the best centres in the USA, France and
UK, and have at their disposition the most advanced techniques
to treat patients with this disease.
Medical
Personnel in the Unit
| Dr. Julio Artieda |
Dr. Miguel Manrique |
| Dr. Bartolomé Bejarano |
Dr. César Viteri |
| Dr. Jorge
Iriarte |
|
Top
5)
Multiple Sclerosis
Fifty Seven thousand Spaniards,
of which some 750 are Navarros, suffer from Multiple Sclerosis
a progressive disease of the nervous sytem that until recently
had no cure. There are now four drugs that can be used to
delay the progression of the disease. Remissions that can
produce serious effects such as blindness or paralysis of
the arms or legs, can also be treated. In the CUN and in collaboration
with other departments, research into immunological treatments
is being carried out in order to continue improving our treatment
of this disease.
Medical
Personnel in the Unit
| Dr.
Purificación de Castro |
Dr.
José Masdeu |
 |
| Dr.
Michel Idoate |
Dr
Pablo Villoslada |
| Dr. José Manuel
Martínez-Lage |
Dr. José Luis
Zubieta |
Top
6)
Neuromuscular disorders
This heterogeneous group of
illnesses can give rise to back or neck pains, pins and needles
in the arms or legs, loss of strength or difficulties in moving.
Some of these illnesses only respond in a limited manner to
treatment such as Ameliotrophic-Lateral Sclerosis (ALS), whereas
others can be treated more successfully such as autoimmune
neuropathies. The success of the treatment depends on the
rapid and accurate diagnosis of the illeness for which various
neurophysiological techniques as well as biochemical and immunological
tests are used. In some cases, it may be necessary to analyse
muscle or nerve biopsies.
Medical
Personnel in the Unit
| Dr. Julio Artieda |
Dr. Asunción Pastor |
| Dr. Purificación de Castro |
Dr. Oscar Soto |
Top
7)
Cerebrovascular illnesses
Cerebral Strokes are the third
most common cause of death in men and the second in women.
In Navarra, approximately 1,000 people suffer from strokes
each year, of which some 30% are fatal in the short term and
a large part of the remaining cases result in severe disabilities
in their victims. This service is centred above all on the
prevention of strokes in conjunction Dr. Javier Diez whose
research deals with risk factors in vascular diseases, another
of the principal lines of study in the CUN.
Medical
Personnel in the Unit
| Dr. Michel Idoate |
Dr. José Masdeu |
| Dr. Eduardo Martínez Vila |
Dr. José Luis Zubieta |
Top
8)
Sleep disorders
Whilst they don't share the
mortality of some of the diseases mentioned above, somnolence
or insomnia are common yet little studied problems that interfere
with the productivity in the workplace and the homelife of
a great many people. The correct diagnosis and treatment of
these problems often requires a study of sleep patterns performed
in a laboratory where the brainwaves and other parameters
can be studied in the sleeping patient.
Medical
Personnel in the Unit
| Dr. Julio Artieda |
Dr. Jorge Iriarte |
Dr. César Viteri |
Top
Other
research areas
1)
Cerebral integration
This line of research is aimed
at elucidating how the diverse brain functions are integrated
to maintain the functional harmony throughout the human brain.
These studies take advantage of current neurophysiological
techniques and have led to the development of novel tchniques
for neuroimaging.
Faculty Personnel
| Manuel
Alegre (doctorado) |
Dr.
Jose Manuel Gimenez Amaya |
Dr.
José Obeso |
| Dr. Javier
Arbizu |
Dr. Jose Luis
Lanciego Perez |
Dr. Asunción
Pastor |
| Dr. Julio
Artieda |
Dr. José Masdeu |
|
Top
2) Information
technology in Neurociences
The explosion of the information
available in neurociencias requieres that this information
is readily assessible to and reaches those that need it. Neuroscientists
and above all doctors that care for patients with neurological
problems will benefit form some of the iniciatives that are
being developed in this section. One example is the
THyNK project ("The
Hypertext Neurological Knowledge-base"), a project
in which hundreds of neurologists around the world are colaborating.
| Dr. José Masdeu |
Dr. Mark Sefton |
|